Poznan University of Life Sciences
Poznan, 60-624, Poland
NCT Number: NCT03438942
The aim of the study is to determine the factors affecting the bioavailability of iron and folic acid during the simultaneous use of iron supplements and folic acid supplements in non-pregnant women of childbearing age.
Looking for future studies?
Notify Me18 year–35 year
Female
Interventional
Not applicable
Poznan, 60-624, Poland
Scientists in the field of nutrition and gynecology and obstetrics have been paying attention to the need of use iron and folate supplements in women of childbearing age. Increased intake of micronutrients in the diet or the use of supplementation does not always bring the expected results, what depends on factors that affect the bioavailability of minerals and vitamins. On the one hand these factors are related to the properties of food intake, e.g. to the presence of other nutrients that can increase or decrease the absorption of folates and iron (eg vitamin C, phytates), and on the other hand the functioning of the body itself, which to a certain extent is determined by genetic factors (e.g., genetically determined reduced activity of methylenetetrahydrofolate reductase [MTHFR], which reduces the bioavailability of folic acid).
The study aims:
In 200 non-pregnant women of childbearing age a blood level of iron and folic acid will be determined. Subjects with low level of blood iron and folic acid will be supplemented with oral iron and folic acid for 3 months. Subjects with proper level of blood iron and folic acid will be a control group. At baseline and at completion of the study (after 3 months) fasting blood will be collected and abovementioned parameters will be estimated.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Individuals with low level of blood folic acid and iron- will receive folic acid and iron supplementation daily, for 3 months
Individuals with proper level of blood folic acid and iron- will not receive folic acid and iron supplementation daily, for 3 months
Time frame: At the baseline
blood folic acid concentrations at baseline
Time frame: after 3 months of treatment
blood folic acid concentrations after 3 months of treatment
Time frame: At the baseline
blood iron concentrations at baseline
Time frame: after 3 months of treatment
blood ron concentrations after 3 months of treatment
Time frame: At the baseline
blood pressure
Time frame: At the baseline
body mass
Time frame: At the baseline
body height
Time frame: At the baseline
Fat tissue % estimated with air displacement plethysmography
Time frame: At the baseline
Muscle tissue % estimated with BodPod (air displacement plethysmography)
Time frame: At the baseline
serum ferritin concentration at the baseline
Time frame: after 3 months of treatment
serum ferritin concentration after 3 months of treatment
Time frame: At the baseline
serum hepcidin concentration at the baseline
Time frame: after 3 months of treatment
serum hepcidin concentration after 3 months of treatment
Time frame: At the baseline
serum homocysteine concentration at the baseline
Time frame: after 3 months of treatment
serum homocysteine concentration after 3 months of treatment
Time frame: At the baseline
Blood total iron-binding capacity at the baseline
Time frame: after 3 months of treatment
Blood total iron-binding capacity after 3 months of treatment
Time frame: At the baseline
polymorphisms of gene encoding divalent metal transporter 1
Time frame: At the baseline
polymorphisms of gene encoding transferrin receptor 2
Time frame: At the baseline
polymorphisms of gene encoding proton-coupled folate transporter
Time frame: At the baseline
polymorphisms of gene encoding reduced folate carrier
Poznan University of Life Sciences
Other
The Study of the Influence of Intestinal and Cellular Iron and Foliate Transporters on Bioavailability of These Micronutrients in the Organism
Acronym: WiMKo
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07566169
Cancer, Chemotherapy-Related Symptoms
Hanoi, Vietnam
View Trial DetailsNCT04841174
Intensive Care Units, Pediatric, Massage
Bakırköy, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT01081587
Malnutrition, Nutrition Disorders
Bron, France
View Trial DetailsNCT04170348
Acute Chest Syndrome, Anemia
New York, United States
View Trial Details